What is Flumist, the new flu vaccine for kids that’s sprayed in their noses?

A fear of needles can stop many children from getting a flu vaccine. But a new nasal spray will be available in 2026. Is your kid eligible?

FDA approves new higher-dose version of Wegovy shots

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off. The U.S. Food and Dr ...
Fierce Pharma

Novo’s Wegovy HD passes muster under FDA national priority voucher program

Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo has achieved another victory as it strives to make the most out of its blockbuster GLP-1 drug in an increasingly ...
PolitiFact

A judge blocked RFK Jr.’s revised vaccine schedule. What does that mean for insurance coverage?

A federal judge recently pushed the legal pause button on several of the Trump administration’s new vaccine policies, the latest development in the United States’ rapidly chan ...

Vaccines facing misinformation spike: WHO experts

Vaccine programmes are being challenged by rising misinformation and an uncertain pipeline for research funding, the World ...
Zacks Investment Research on MSN

Here is what to know beyond why Novavax, Inc. (NVAX) is a trending stock

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
Hosted on MSN

COVID-19 vaccine maker Novavax swings to profit as sales climb

Novavax Inc. NVAX shares are up on Thursday following the company’s announcement of its fourth-quarter and full-year 2025 financial results. Novavax reported fourth-quarter earnings of 11 cents, a ...
Benzinga.com

COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb

Novavax reported fourth-quarter earnings of 11 cents, a shift from a loss of 51 cents a year ago. evenue for the fourth quarter was $147 million, a 67% year-over-year increase. Novavax on Thursday ...
U.S. News & World Report

Novavax Raises Revenue Forecast on Boost From Vaccine Deals, Shares Soar

Feb 26 (Reuters) - Novavax ⁠raised ⁠its adjusted revenue forecast for ⁠2026 on Thursday, banking on milestone payments from licensing and supply deals for its shots, although it noted that the current ...
The New York Times

Surgeon General Nominee Dodges Senators’ Questions on Vaccines

new video loaded: Surgeon General Nominee Dodges Senators’ Questions on Vaccines transcript Dr. Casey Means, a wellness influencer and supporter of Health Secretary Robert F. Kennedy Jr., deflected ...
GEN

StockWatch: FDA Reversal Boosts Moderna, But Not Other Vaccine Companies

Moderna researchers at work in the company’s lab. The FDA’s reversal of its earlier refusal to review mRNA-1010, the seasonal flu vaccine being developed by Moderna accelerated a revival of its shares ...